NK cells, cultured with IL-2, IL-15 or IL-15/IL-18 and in the presence of either BRAF-i or MEK-i, were analyzed for their ability to kill different melanoma cell lines including MeCoP, MeTA, MeDeBO and FO-1. The gene discussed is IL18; the disease is melanoma.